CS, H., D, H., MS, T., TJ, P., Y, M., A, P., . . . RJ, B. (2024). TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models. Molecular therapy. Oncology, 32(3), 200862. https://doi.org/10.1016/j.omton.2024.200862
Chicago Style (17th ed.) CitationCS, Hackett, et al. "TYRP1 Directed CAR T cells Control Tumor Progression in Preclinical Melanoma Models." Molecular Therapy. Oncology 32, no. 3 (2024): 200862. https://doi.org/10.1016/j.omton.2024.200862.
MLA (9th ed.) CitationCS, Hackett, et al. "TYRP1 Directed CAR T cells Control Tumor Progression in Preclinical Melanoma Models." Molecular Therapy. Oncology, vol. 32, no. 3, 2024, p. 200862, https://doi.org/10.1016/j.omton.2024.200862.
Warning: These citations may not always be 100% accurate.